This paper critically analyzes a 1996 retrospective cohort study by Harpaz et al. examining the transmission of hepatitis B virus (HBV) from an HBsAg-positive thoracic surgeon to his patients across two hospitals between July 1991 and July 1992. Of 144 surgical patients reviewed, 19 (13%) developed HBV infection post-surgery, while none of 124 control patients operated on by other surgeons tested positive. The paper evaluates serological evidence, identifies procedural violations by the surgeon, assesses the study's limitations regarding transmission routes, and discusses broader implications for infection control policy, HBV vaccination requirements, and the restriction of HBeAg-positive healthcare workers from exposure-prone procedures.
The paper demonstrates source-based critical analysis: it summarizes a primary study, identifies what it establishes (the source of infection), and then clearly delineates what it fails to establish (the precise transmission route). This ability to separate confirmed findings from unresolved questions is a hallmark of rigorous academic review.
The paper opens with epidemiological context before introducing the Harpaz et al. study. It then walks through the study's methodology and findings, transitions to a critical evaluation of its weaknesses, and closes with policy recommendations supported by additional references. The structure mirrors a standard article critique format appropriate for an undergraduate health sciences course.
Hepatitis B and C virus transmission during surgical interventions has become a critical concern in modern healthcare. Healthcare workers are especially prone to acquiring HBV and HCV infections from patients, and vice versa. Statistics derived from several studies over the last decade and a half reveal a 4% infection rate among patients of surgeons who test positive for HBeAg.[1]
The study under consideration by Harpaz et al. (1996) analyzes the important clinical issue of hepatitis B virus (HBV) transmission from a previously infected surgeon to his patients. The physician under study tested positive for the hepatitis B surface antigen (HBsAg) and anti-HBc antibody, and was diagnosed with jaundice in February 1992. However, by March 1992, when he had symptomatically recovered, he resumed his duties as a surgeon in two hospitals. This retrospective cohort study analyzed the period between July 1991 and July 1992 and reviewed a total of 144 patients who received surgical care from the particular physician.[2]
The researchers used chart reviews, interviews, and serologic testing for patients who received surgical care from the physician under study at two hospitals during the aforementioned study period. A total of 19 patients out of 144 (13%) study subjects — those who were operated on by the surgeon — developed HBV infection post-surgery.
As a control group, the researchers also observed 124 patients who received surgical care from other thoracic surgeons at one of the hospitals under study. This comparison was useful in identifying any other hospital-based potential infection sources. The fact that none of these 124 control subjects tested positive for HBV post-surgery clearly ruled out infection from other nosocomial sources.
Serological testing further revealed that the HBsAg subtype adW2 found in the surgeon was also present in 13 of the infected subjects. Furthermore, HBV DNA sequence data from the surgeon matched that of 9 case subjects who were also tested. On the basis of this evidence, the study correctly identified the physician under study as the source of infection.[2]
The researchers reported identifying traces of HBV DNA and HBsAg from lesions formed during a one-hour suture simulation test. This retrospective study concluded that lesions formed during suturing, in combination with glove failure, could have been the possible route of HBV transmission. However, the study did not provide conclusive evidence as to the precise route of transmission.
Study results revealed that cardiac transplantation procedures carried a significantly greater risk factor for HBV infection, with a relative risk of 4.9 (95% confidence interval, 1.5 to 15.5). This finding underscores the heightened vulnerability of patients undergoing complex, high-exposure surgical procedures.
You’re 45% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.